Acquisition Synergy Accriva Diagnostics is now part of Instrumentation Laboratory, indicating potential cross-sell opportunities across IL’s broader coagulation, platelet aggregation, CO-Oximetry, and point-of-care portfolios to leverage existing distributor and sales channels.

POC Growth IL has a history of expanding its point-of-care offerings; targeting labs and hospitals with Accriva’s POC coagulation and incision devices could accelerate adoption of integrated IL POC solutions.

New Analytics IL’s deployment of iQM and remote support solutions suggests a market need for connected analytics; offering enhanced remote monitoring, quality management, and data integration services to current customers could drive recurring revenue.

Mid to High Volume Fit Accriva’s presence and revenue profile align with mid to high-volume clinical labs; opportunities exist to position advanced ACL TOP, coagulation, and chromogenic/immuno assays within IL’s enterprise accounts seeking scalable instrumentation.

Global Expansion With IL’s international footprint and Accriva’s ProDx remote capabilities, there is potential to expand service contracts, support networks, and training programs in new regions, leveraging combined installed base and lifecycle services.